Nonprofit · EIN 83-2302258
WASHINGTON INSTITUTE FOR COAGULATION
Tax-exempt · SEATTLE, WA 98101
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $112,675,357 | $101,694,334 | $10,981,023 | $87,751,207 | $22,741,079 | $65,010,128 |
| June 30, 2024 | 990 | $122,490,634 | $108,898,367 | $13,592,267 | $78,674,468 | $24,646,432 | $54,028,036 |
| June 30, 2023 | 990 | $114,481,287 | $104,365,786 | $10,115,501 | $74,267,913 | $33,833,067 | $40,434,846 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $87,876
- of which government grants
- $87,876
- Program service revenue
- $110,795,343
- Investment income
- $1,769,155
- Net gain from sales of assets
- -$19,121
- Other revenue
- $22,983
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $809,284
- Other salaries and wages
- $4,856,595
- Salaries, compensation and benefits (total)
- $6,965,567
- Professional fundraising fees
- $0
- Legal fees
- $12,226
- Accounting fees
- $66,833
- Occupancy
- $1,360,530
- Travel
- $77,596
- Depreciation
- $335,981
- Program services (functional)
- $99,185,361
- Management and general (functional)
- $2,508,973
Balance sheet and other
- Total assets, start of year
- $78,674,468
- Total assets, end of year
- $87,751,207
- Total liabilities, end of year
- $22,741,079
- Net assets, end of year
- $65,010,128
- Land, buildings and equipment
- $2,827,836
- Net assets without donor restrictions
- $65,010,128
- Gross receipts
- $112,710,864
- Employees
- 55
- Volunteers
- 6
- Year formed
- 2018
- State of legal domicile
- WA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| REBECCA KRUSE-JARRES MD | EXECUTIVE/MEDICAL DIRECTOR Trustee or director, Officer | 40 | $297,961 | $70,987 |
| KIM SNYDER | CFO/COO (THRU 11/24)/BOARD TREASURER Trustee or director, Officer | 40 | $183,716 | $23,680 |
| HSIN KAI A CHEN | PHARMACY DIRECTOR Key employee | 40 | $174,064 | $31,989 |
| JENNIFER LAMHARZI | CLINICAL NURSE MANAGER Highest-paid employee | 40 | $150,207 | $32,465 |
| HEEBEEN KIM | CLINICAL PHARMACIST Highest-paid employee | 40 | $155,485 | $20,312 |
| ANNE JEZZAMINE CHOI | NURSE PRACTITIONER Highest-paid employee | 40 | $141,912 | $27,962 |
| AMY HARRIS | CONTROLLER Highest-paid employee | 40 | $145,335 | $15,632 |
| KHOA LE | CLINICAL PHARMACIST Highest-paid employee | 40 | $141,860 | $11,634 |
| EVA SZYSZKA | CFO/COO Officer | 40 | $36,525 | $1,545 |
| NEIL JOSEPHSON MD | PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| KRISHNA JAFA | VICE PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| KRISTIAN PRILL HAMILTON | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| ROSHNI KULKARNI | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| LORI JACOBSEN-TEWS | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| SETHU MEIYAPPAN | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
990 for the year ended June 30, 2024: 12 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| REBECCA KRUSE-JARRES MD | EXECUTIVE/MEDICAL DIRECTOR Trustee or director, Officer | 40 | $284,614 | $66,345 |
| KIM R SNYDER | CHIEF FINANCIAL OFFICER/COO Officer | 40 | $245,217 | $13,099 |
| HSIN KAI A CHEN | PHARMACY DIRECTOR Key employee | 40 | $164,615 | $23,245 |
| HEEBEEN KIM | CLINICAL PHARMACIST Highest-paid employee | 40 | $145,592 | $25,060 |
| CATLIN T GOODFRIEND | CLINICAL PHARMACIST Highest-paid employee | 40 | $134,579 | $23,894 |
| ANNE JEZZAMINE Y CHOI | NURSE PRACTITIONER Highest-paid employee | 40 | $127,447 | $25,705 |
| RENEE M KILLIAN | CLINCIAL NURSE COORDINATOR Highest-paid employee | 40 | $128,294 | $23,404 |
| KHOA C LE | CLINICAL PHARMACIST Highest-paid employee | 40 | $134,401 | $10,587 |
| KRISTIAN PRILL HAMILTON | PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| NEIL JOSEPHSON MD | VICE PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| KRISHNA JAFA | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| ROSHNI KULKARNI | BOARD DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended June 30, 2023: 11 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| REBECCA KRUSE-JARRES MD | EXECUTIVE/MEDICAL DIRECTOR Trustee or director, Officer | 40 | $296,760 | $70,020 |
| NICOLE JOBSON | OPERATIONS DIRECTOR Officer | 40 | $169,896 | $13,329 |
| HEEBEEN KIM | CLINICAL PHARMACIST Highest-paid employee | 40 | $139,750 | $24,066 |
| ANNE JEZZAMINE CHOI | NURSE PRACTITIONER Highest-paid employee | 40 | $125,172 | $24,777 |
| RENEE KILLIAN | CLINIC NURSE COORDINATOR Highest-paid employee | 40 | $120,828 | $22,177 |
| BRUNO STEINER | PHYSICAL THERAPY & MSKUS PROGRAM MGR Highest-paid employee | 40 | $118,709 | $21,985 |
| CATLIN GOODFRIEND | CLINICAL PHARMACIST Highest-paid employee | 40 | $118,701 | $21,811 |
| KIM SNYDER | CHIEF FINANCIAL OFFICER/COO Officer | 40 | $28,847 | $0 |
| KRISTIAN PRILL HAMILTON | PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| NEIL JOSEPHSON MD | VICE PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| KRISHNA JAFA | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 701 PIKE ST STE 1900, SEATTLE, WA 98101-3932
- Mailing address (990-N for 2022)
- 2351 Hobart Ave SW, Seattle WA 98116
- Principal officer (990 for 2024)
- EVA SZYSZKA, 701 PIKE STREET 1900, SEATTLE, WA 98101
- Principal officer (990-N for 2022)
- Bruno Steiner, 2351 Hobart Ave SW, Seattle WA 98116
- Signed the 990
- EVA SZYSZKA, CFO/COO
- Phone
- (206) 614-1200
- Website
- WWW.WACBD.ORG
- Return prepared by
- CLARK NUBER PS
Mission
THE WASHINGTON CENTER FOR BLEEDING DISORDERS IS DEDICATED TO ASSURING OPTIMAL HEALTH FOR PEOPLE WITH BLEEDING DISORDERS THROUGH COMPREHENSIVE CARE, EDUCATION, AND RESEARCH.
Program accomplishments
- CLINICAL SERVICES: AS A RECOGNIZED HEMOPHILIA TREATMENT CENTER AND ACENTER OF EXCELLENCE, WE ARE COMMITTED TO THE WELLBEING OF PATIENTSWITH AN INHERITED BLEEDING DISORDER ACROSS THE STATE OF WASHINGTON,NEIGHBORING STATES, AND ALASKA. WE ARE DEDICATED TO REFINED DIAGNOSISAND ASSESSMENT, SECURE ACCESS TO THERAPIES AND COMPREHENSIVETREATMENT PLANNING AND READILY AVAILABLE CONSULTATION. WE STRIVE TOFOSTER OUR PATIENTS' AUTONOMY TO SAFELY CARE FOR THEIR DISORDER ANDCAUSE MINIMAL DISRUPTION TO THEIR LIVES. A MULTIDISCIPLINARY TEAM OFHEALTH-CARE PROFESSIONALS ADDRESSES CONCERNS INCLUDING DIAGNOSIS,TREATMENT, EDUCATION, HEALTH INSURANCE, ORTHOPEDICS, AND DENTISTRY.EXPERT PEDIATRIC SERVICES ARE COORDINATED WITH SPECIALISTS AT SEATTLECHILDREN'S HOSPITAL IN SEATTLE, PROVIDENCE SACRED HEART MEDICAL CENTERAND CHILDREN'S HOSPITAL IN SPOKANE, AND MARY BRIDGE MEDICAL CENTERAND CHILDREN'S HOSPITAL IN TACOMA. OUTREACH CLINICS ARE CONDUCTED INTRI-CITIES, YAKIMA, SPOKANE, WENATCHEE, OLYMPIA, AND SEDRO-WOOLLEY.HOME VISITS TO FAMILIES AND IN-SERVICE MEETINGS WITH HEALTH-CAREPROFESSIONALS ARE PROVIDED THROUGHOUT THE STATE OF WASHINGTON.PROGRAM STAFF ALSO COORDINATE COMMUNITY RESOURCES FOR HEMOPHILIACARE, EMERGENCY ROOM TREATMENT, INVASIVE PROCEDURES, AND OTHERMEDICAL SPECIALTY CLINICS.Expenses $8,408,236 · revenue $397,679
- PHARMACY SERVICES: AS AN INTEGRAL PART OF OUR COMPREHENSIVE CAREMODEL, OUR PHARMACY PROVIDES BLOOD CLOTTING FACTOR PRODUCTS TOPATIENTS AND HOSPITAL PROVIDERS THROUGHOUT THE STATE OF WASHINGTONAND PARTS OF ALASKA, MONTANA, AND IDAHO. PHARMACY SERVICES AT THEWASHINGTON CENTER FOR BLEEDING DISORDERS (WACBD) HAS TWO PRIMARYCOMPONENTS, A LICENSED HEMOPHILIA SPECIALTY PHARMACY, AND A LICENSEDPHARMACEUTICAL WHOLESALER. THE HEMOPHILIA SPECIALTY PHARMACYSUPPORTS CLINICAL OPERATIONS FOR MORE THAN 550 ADULT PATIENTS WHORECEIVE CARE AT OUR MAIN FACILITY IN SEATTLE, WA AND AT OUTREACH CLINICSTHROUGHOUT THE STATE OF WASHINGTON. THE PHARMACY ALSO PROVIDESSUPPORT TO THE MORE THAN 450 CHILDREN WITH BLEEDING DISORDERS WHORECEIVE CARE AT OUR AFFILIATED CHILDREN'S CENTERS LOCATED IN TACOMA,SEATTLE, AND SPOKANE, WASHINGTON. PATIENT SERVICES ARE PROVIDEDPRIMARILY THROUGH THE FILLING OF MAIL ORDER PRESCRITIONS AND PATIENTCOUNSELING ON FACTOR AND NON-FACTOR PRESCRIPTION MEDICATIONS FORTREATMENT OF VARIETY OF BLEEDING DISORDERS. THE WHOLESALE OPERATIONSPROVIDE 24 HOUR A DAY/7 DAY A WEEK SUPPORT TO WACBD CLINICALCONSULTANTS AND OVER 70 HOSPITALS IN WASHINGTON STATE, WHO REQUIREBLOOD FACTOR REPLACEMENT PRODUCTS AND SPECIALTY PHARMACEUTICALSFOR TREATMENT OF PATIENTS WITH BLEEDING DISORDERS.Expenses $90,777,125 · revenue $110,397,664
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 83-2302258
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (509(a)(2))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2018
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G99)
- Assets (IRS master file)
- $87,751,207
- Income (IRS master file)
- $112,710,864
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $112,675,357 | $101,694,334 | $87,751,207 | IRS |
| 990 | June 2024 | $122,490,634 | $108,898,367 | $78,674,468 | IRS |
| 990-N for 2022 Officer: Bruno Steiner | June 30, 2023 | ≤ $50,000 receipts | – | – | e-Postcard |
| 990 | June 2023 | $114,481,287 | $104,365,786 | $74,267,913 | XML |
| 990 | June 2022 | $53,405,497 | $49,511,083 | $62,927,219 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990-N for 2019 Officer: Rebecca Kruse-Jarres | December 31, 2019 | ≤ $50,000 receipts | – | – | e-Postcard |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 83-2302258).
Questions about WASHINGTON INSTITUTE FOR COAGULATION
- What is the EIN of WASHINGTON INSTITUTE FOR COAGULATION?
- The employer identification number (EIN) of WASHINGTON INSTITUTE FOR COAGULATION is 83-2302258.
- Is WASHINGTON INSTITUTE FOR COAGULATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2018.
- Are donations to WASHINGTON INSTITUTE FOR COAGULATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does WASHINGTON INSTITUTE FOR COAGULATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of WASHINGTON INSTITUTE FOR COAGULATION due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did WASHINGTON INSTITUTE FOR COAGULATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of WASHINGTON INSTITUTE FOR COAGULATION?
- The 990 for the year ended June 30, 2025 names EVA SZYSZKA.
- Who are the officers and directors of WASHINGTON INSTITUTE FOR COAGULATION?
- The 990 for the year ended June 30, 2025 lists 15 people; 9 received compensation from the organization, the highest $297,961 (REBECCA KRUSE-JARRES MD, EXECUTIVE/MEDICAL DIRECTOR).
- How much revenue does WASHINGTON INSTITUTE FOR COAGULATION have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $112,675,357, expenses of $101,694,334 and total assets of $87,751,207 at year end.
Other nonprofits in SEATTLE
- MAXAID EIN 35-2577906 · last filed 990 for 2024
- LIFELONG HEALTH FOR ALL EIN 91-1215715 · last filed 990 for 2024
- PROVAIL EIN 91-0593488 · last filed 990 for 2025
- PEER WASHINGTON EIN 91-1327257 · last filed 990 for 2024
- SAINT JOHN S CANCER INSTITUTE EIN 95-4291515 · last filed 990 for 2024
- SHOUT IT NOW EIN 26-0597175 · last filed 990 for 2024
- BOYER CHILDRENS CLINIC EIN 91-1316838 · last filed 990 for 2024
- BUILDING CHANGES EIN 91-1410450 · last filed 990 for 2024
All nonprofits in SEATTLE · Washington · Voluntary health associations and medical disciplines